Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by DryBoneson Sep 30, 2018 12:22am
113 Views
Post# 28716248

re - PLI's history of deals.

re - PLI's history of deals.It is not that PLI can't get a deal  They have gotten lots of deals in the past. It is just that most turned out to be turds in the soup.

I can list a few:
American red cross
Algeria
Russia
China
I think there was even one in Brazil.

So far none with a credible international pharmacuetical, at least that I can think of.  I hope that the reason for that is not that the science ain't great.  As for Billion dollar deals.  Does anyone know of one for a biotherapeutic?  I'd love to hear of one.
Bullboard Posts